|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / NZvGlvHeGgAcEvJoFSl |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Luigi Гость |
Добавлено: 22-06-2022 08:55 |
|
I'm doing an internship how does spiriva-respimat work ** PROSENSA, $7.93, down 67 pct (1:17 p.m. ET) An experimental drug for Duchenne muscular dystrophy fromGlaxoSmithKline and Prosensa failed to meet its goal in alate-stage clinical trial, the companies said on Friday. Thedrug, drisapersen, did not show a statistically significantimprovement in the distance that patients could walk in sixminutes compared to a placebo in the Phase three test. |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / NZvGlvHeGgAcEvJoFSl |